Dr. M. Vishwanath is experienced in managing oncology emergencies such as tumor lysis syndrome (TLS), superior vena cava (SVC) syndrome, neutropenic sepsis, severe treatment-related toxicities, and metabolic complications.
Using CTCAE and NCCN guidelines, he carefully evaluates and manages chemotherapy-related adverse effects to ensure patient safety. Early recognition and prompt intervention help reduce complications and allow patients to continue treatment safely.
Every patient is monitored closely throughout therapy, and supportive medications are provided whenever required to minimize side effects and improve treatment tolerance.
Highlights